Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges in implementing CD4 testing in resource-limited settings.
Peter T, Badrichani A, Wu E, Freeman R, Ncube B, Ariki F, Daily J, Shimada Y, Murtagh M. Peter T, et al. Among authors: daily j. Cytometry B Clin Cytom. 2008;74 Suppl 1:S123-30. doi: 10.1002/cyto.b.20416. Cytometry B Clin Cytom. 2008. PMID: 18348208 Free article. Review.
Rapid diagnostic tests for malaria.
Visser T, Daily J, Hotte N, Dolkart C, Cunningham J, Yadav P. Visser T, et al. Among authors: daily j. Bull World Health Organ. 2015 Dec 1;93(12):862-6. doi: 10.2471/BLT.14.151167. Epub 2015 Sep 25. Bull World Health Organ. 2015. PMID: 26668438 Free PMC article.
Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination.
Greenhouse B, Daily J, Guinovart C, Goncalves B, Beeson J, Bell D, Chang MA, Cohen JM, Ding X, Domingo G, Eisele TP, Lammie PJ, Mayor A, Merienne N, Monteiro W, Painter J, Rodriguez I, White M, Drakeley C, Mueller I; Malaria Serology Convening. Greenhouse B, et al. Among authors: daily j. Gates Open Res. 2019 Feb 12;3:131. doi: 10.12688/gatesopenres.12897.1. eCollection 2019. Gates Open Res. 2019. PMID: 31172051 Free PMC article.
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.
Marconi VC, Sunpath H, Lu Z, Gordon M, Koranteng-Apeagyei K, Hampton J, Carpenter S, Giddy J, Ross D, Holst H, Losina E, Walker BD, Kuritzkes DR; South Africa Resistance Cohort Study Team. Marconi VC, et al. Clin Infect Dis. 2008 May 15;46(10):1589-97. doi: 10.1086/587109. Clin Infect Dis. 2008. PMID: 18419495 Free PMC article.
Outcomes after virologic failure of first-line ART in South Africa.
Murphy RA, Sunpath H, Lu Z, Chelin N, Losina E, Gordon M, Ross D, Ewusi AD, Matthews LT, Kuritzkes DR, Marconi VC; South Africa Resistance Cohort Study Team. Murphy RA, et al. AIDS. 2010 Apr 24;24(7):1007-12. doi: 10.1097/QAD.0b013e3283333639. AIDS. 2010. PMID: 20397305 Free PMC article.
268 results